Thomas Kramps
Nuernberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Introduction to RNA Vaccines Post COVID-19.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 30, 2024
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 13, 2023
Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 04, 2023
Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 08, 2021
A thermostable messenger RNA based vaccine against rabies.
Journal: PLoS neglected tropical diseases
Published: May 31, 2017
Introduction to RNA Vaccines.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 18, 2016
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 28, 2016
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.
Journal: PLoS neglected tropical diseases
Published: January 04, 2016
Messenger RNA-based vaccines: progress, challenges, applications.
Journal: Wiley interdisciplinary reviews. RNA
Published: May 28, 2013
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.
Journal: Nature biotechnology
Published: July 02, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026